Cannabis gummies aim to ease Post-Surgery recovery for bladder cancer patients
NCT ID NCT07577999
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This early-stage study will give 20 bladder cancer patients cannabigerol (CBG) gummies before and after surgery to see if they are safe and tolerable. The goal is to improve quality of life and reduce symptoms during recovery. Researchers will monitor side effects and how well patients tolerate the gummies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cannabigerol (CBG) gummies
- What this could lead to
- If it works, this could point toward a way to help patients feel better and recover more comfortably after bladder cancer surgery.
- What could go wrong
- This is a very early, small pilot study with only 20 people. It is not designed to prove effectiveness, and side effects like dizziness or nausea are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-METASTATIC BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford University
Palo Alto, California, 94304, United States